Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Andersson, Tomas LG"'
Autor:
Krychtiuk, Konstantin A., Andersson, Tomas LG, Bodesheim, Ulrike, Butler, Javed, Curtis, Lesley H., Elkind, Mitchell, Hernandez, Adrian F., Hornik, Christoph, Lyman, Gary H., Khatri, Pooja, Mbagwu, Michael, Murakami, Masahiro, Nichols, Gwen, Roessig, Lothar, Young, Anne Quinn, Schilsky, Richard L., Pagidipati, Neha
Publikováno v:
In American Heart Journal April 2024 270:23-43
Autor:
Buhl Roland, Kuna Piotr, Peters Matthew J, Andersson Tomas LG, Naya Ian P, Peterson Stefan, Rabe Klaus F
Publikováno v:
Respiratory Research, Vol 13, Iss 1, p 59 (2012)
Abstract Background Divergent strategies have emerged for the management of severe asthma. One strategy utilises high and fixed doses of maintenance treatment, usually inhaled corticosteroid/long-acting β2-agonist (ICS/LABA), supplemented by a short
Externí odkaz:
https://doaj.org/article/f9b81925e8d94815af65fbd5988b0c38
Autor:
Fleming TR; 1 Department of Biostatistics, University of Washington, Seattle, WA, USA., DeMets DL; 2 University of Wisconsin-Madison, Madison, WI, USA., Roe MT; 3 Duke Clinical Research Institute (DCRI), Duke University Medical Center, Durham, NC, USA., Wittes J; 4 Statistics Collaborative, Inc., Washington, DC, USA., Calis KA; 5 Center for Drug Evaluation and Research (CDER), FDA, Silver Spring, MD, USA.; 6 National Institute of Child Health and Human Development (NICHD), NIH, Bethesda, MD, USA., Vora AN; 3 Duke Clinical Research Institute (DCRI), Duke University Medical Center, Durham, NC, USA., Meisel A; 7 University of Pittsburgh, Pittsburgh, PA, USA., Bain RP; 8 Merck Research Laboratories, North Wales, PA, USA., Konstam MA; 9 Tufts Medical Center, Boston, MA, USA., Pencina MJ; 3 Duke Clinical Research Institute (DCRI), Duke University Medical Center, Durham, NC, USA., Gordon DJ; 10 National Heart, Lung and Blood Institute (NHLBI), NIH, Bethesda, MD, USA., Mahaffey KW; 11 Stanford University School of Medicine, Stanford University, Stanford, CA, USA., Hennekens CH; 12 Florida Atlantic University, Boca Raton, FL, USA., Neaton JD; 13 University of Minnesota, Minneapolis, MN, USA., Pearson GD; 10 National Heart, Lung and Blood Institute (NHLBI), NIH, Bethesda, MD, USA., Andersson TL; 14 AstraZeneca, Mölndal, Sweden., Pfeffer MA; 15 Brigham and Women's Hospital, Boston, MA, USA., Ellenberg SS; 16 University of Pennsylvania, Philadelphia, PA, USA.
Publikováno v:
Clinical trials (London, England) [Clin Trials] 2017 Apr; Vol. 14 (2), pp. 115-123. Date of Electronic Publication: 2017 Feb 01.
Autor:
Fleming TR; 1 Department of Biostatistics, University of Washington, Seattle, WA, USA., DeMets DL; 2 University of Wisconsin, Madison, WI, USA., Roe MT; 3 Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA., Wittes J; 4 Statistics Collaborative, Inc., Washington, DC, USA., Calis KA; 5 Center for Drug Evaluation and Research, U.S. Food and Drug Administration (FDA), Silver Spring, MD, USA.; 6 National Institute of Child Health and Human Development, National Institutes of Health (NIH), Bethesda, MD, USA., Vora AN; 3 Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA., Meisel A; 7 University of Pittsburgh, Pittsburgh, PA, USA., Bain RP; 8 Merck Research Laboratories, North Wales, PA, USA., Konstam MA; 9 Tufts Medical Center, Boston, MA, USA., Pencina MJ; 3 Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA., Gordon DJ; 10 National Heart, Lung and Blood Institute, National Institutes of Health (NIH), Bethesda, MD, USA., Mahaffey KW; 11 Stanford University School of Medicine, Stanford, CA, USA., Hennekens CH; 12 Florida Atlantic University, Boca Raton, FL, USA., Neaton JD; 13 University of Minnesota, Minneapolis, MN, USA., Pearson GD; 10 National Heart, Lung and Blood Institute, National Institutes of Health (NIH), Bethesda, MD, USA., Andersson TL; 14 AstraZeneca, Mölndal, Sweden., Pfeffer MA; 15 Brigham and Women's Hospital, Boston, MA, USA., Ellenberg SS; 16 University of Pennsylvania, Philadelphia, PA, USA.
Publikováno v:
Clinical trials (London, England) [Clin Trials] 2017 Apr; Vol. 14 (2), pp. 126-127. Date of Electronic Publication: 2017 Jan 31.